8EC-30707-48564 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-08
Dose 1 — Moderna
2021-12-06
Dose 2 — Moderna
2022-06-23
Registered in v-safe
2022-11-02
Dose 3 — Moderna
2022-12-07
Survey response — 12 months, dose 2, dependent
MedDRA: Conjunctivitis, Cough, Eye discharge, Ocular hyperaemia, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Eye redness/discharge x 2 (along with runny nose/cough). Polytrim eye drops for conjunctivitis both times.

MedDRA releases: 2024-11 · check-in free text available
2022-12-07
Report sent to call center — 12 months, dose 2, dependent
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-08
Call 1 — Requested Callback
2022-12-15
Call 2 — Left Voicemail
2023-05-07
Health check-in — 6 months, dose 3, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-08	Moderna	No
2	2021-12-06	Moderna	No
3	2022-11-02	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-12-07	Unsuccessful

Free text

Release 12 — 12 months, dose 2, dependent

2022-12-07

Symptoms: Eye redness/discharge x 2 (along with runny nose/cough). Polytrim eye drops for conjunctivitis both times.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	Cough	·	·	✓
SD	Eye discharge	·	·	✓
SD	Ocular hyperaemia	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release